Therapeutic Use of hES-derived Somatic Cells

hES 衍生体细胞的治疗用途

• 批准号: 7681104
• 负责人: JAMES RHEINWALD
• 金额: $ 4.55万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-01 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7681104
• 关键词: Address; Amino Acids; Antigen Presentation; Antigen-Presenting Cells; Antigens; B-Lymphocytes; Binding; CD1 Antigens; Dendritic Cells; Depth; Development; Disease; Environment; Epidermis; Frequencies; Granulocyte-Macrophage Colony-Stimulating Factor; Head; Host Defense; Human; Human Development; In Vitro; Infection; Inflammatory; Insulin-Dependent Diabetes Mellitus; Interleukin-4; Langerhans cell; Lipids; Lymph Node Tissue; Mediating; Mus; Natural Killer Cells; Nature; Numbers; Organ; Peptides; Phenotype; Play; Polysaccharides; Population; Psoriasis; Role; Sampling; Skin; Somatic Cell; Structure; System; T-Cell Receptor; T-Lymphocyte; Testing; Therapeutic Uses; Thymus Gland; antigen binding; base; cytokine; microbial; monocyte; mycobacterial; peripheral blood; tumor

Abstract Not Provided.

未提供摘要。